Peptic Ulcers: Slideshow


Many research efforts are currently under way in the field of peptic ulcer disease.

Research Efforts in Peptic Ulcer Disease

  • H pylori vaccine

  • Improved H pylori drug eradication regimens

  • Clinical testing of long-acting proton-pump inhibitors

  • Identification of which patients will be refractory to initial
    pharmacotherapy based on genetic polymorphisms

  • New antisecretory therapies (ie, potassium-competitive acid blockers)

Contributor Information

Lars Grimm, MD, MHS
House Staff
Department of Internal Medicine
Duke University Medical Center
Durham, North Carolina

Lars Grimm, MD, MHS, has disclosed no relevant financial relationships.

Contributor Information

David A. Johnson, MD
Professor of Medicine
Chief of Gastroenterology
Eastern Virginia Medical School
Norfolk, Virginia

David A. Johnson, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP, Takeda
Pharmaceuticals North America, Inc.; Eisai Inc.; Novartis Pharmaceuticals
Served as a speaker or a member of a speakers bureau for: AstraZeneca
Pharmaceuticals LP; Takeda Pharmaceuticals North America, Inc.
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP;
Takeda Pharmaceuticals North America, Inc.